Page last updated: 2024-08-21
hydrazine and dnk 333
hydrazine has been researched along with dnk 333 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Anderson, GP; Ball, HA; Bammerlin, H; Gerspacher, M; Hauser, K; Kimmel, S; La Vecchia, L; Mah, R; Pawelzik, V; Ryffel, K; Subramanian, N; von Sprecher, A | 1 |
Other Studies
1 other study(ies) available for hydrazine and dnk 333
| Article | Year |
|---|---|
Dual neurokinin NK(1)/NK(2) antagonists: N-[(R,R)-(E)-1-arylmethyl-3-(2-oxo-azepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamides and 3-[N'-3,5-bis(trifluoromethyl)benzoyl-N-arylmethyl-N'-methylhydrazino]-N-[(R)-2-oxo-azepan-3-yl]propion
Topics: Animals; Aza Compounds; Benzamides; CHO Cells; Cricetinae; Drug Evaluation, Preclinical; Humans; Hydrazines; Inhibitory Concentration 50; Neurokinin-1 Receptor Antagonists; Receptors, Neurokinin-1; Receptors, Neurokinin-2; Structure-Activity Relationship | 2001 |